Liquid biopsy of cerebrospinal fluid enables selective profiling of glioma molecular subtypes at first clinical presentation. Orzan F, De Bacco F, Lazzarini E, Crisafulli G, et al. Clin Cancer Res 2023 Jan 17:CCR-22-2903. doi: 10.1158/1078-0432.CCR-22-2903.

Read + Share

Amedeo Smart

Independent Medical Education

Orzan F, De Bacco F, Lazzarini E, Crisafulli G, et al. Liquid biopsy of cerebrospinal fluid enables selective profiling of glioma molecular subtypes at first clinical presentation. Clin Cancer Res 2023 Jan 17:CCR-22-2903. doi: 10.1158/1078-0432.CCR-22-2903.
PMID: 36648487